560 related articles for article (PubMed ID: 31562940)
1. The impact of dupilumab on patch testing and the prevalence of comorbid allergic contact dermatitis in recalcitrant atopic dermatitis: A retrospective chart review.
Raffi J; Suresh R; Botto N; Murase JE
J Am Acad Dermatol; 2020 Jan; 82(1):132-138. PubMed ID: 31562940
[TBL] [Abstract][Full Text] [Related]
2. Variable impact of dupilumab on patch testing results and allergic contact dermatitis in adults with atopic dermatitis.
Stout M; Silverberg JI
J Am Acad Dermatol; 2019 Jul; 81(1):157-162. PubMed ID: 30885752
[TBL] [Abstract][Full Text] [Related]
3. Characterization of Residual Facial Dermatitis during Dupilumab Therapy: A Retrospective Chart Review to Delineate the Potential Role of Expanded Series Patch Testing.
Ashbaugh AG; Murase EM; Raffi J; Botto N; Murase JE
Dermatitis; 2022 Jan-Feb 01; 33(1):51-61. PubMed ID: 35029349
[TBL] [Abstract][Full Text] [Related]
4. Patch Testing in Patients With Severe Atopic Dermatitis Treated With Dupilumab: A Multicentric Approach in Spain.
Docampo-Simón A; Sánchez-Pujol MJ; Pastor-Nieto MA; Giménez-Arnau A; Rodríguez-Serna M; Serra-Baldrich E; Miquel J; Sánchez-Pérez J; Sanz-Sánchez T; Zaragoza-Ninet V; Sánchez-Pedreño P; Carrascosa JM; Gatica-Ortega ME; Fernández-Redondo V; Córdoba-Guijarro S; González-Pérez R; Silvestre JF
Dermatitis; 2023; 34(4):315-322. PubMed ID: 37001174
[No Abstract] [Full Text] [Related]
5. Dupilumab for Allergic Contact Dermatitis: An Overview of Its Use and Impact on Patch Testing.
Johnson H; Adler BL; Yu J
Cutis; 2022 May; 109(5):265-267. PubMed ID: 35856769
[TBL] [Abstract][Full Text] [Related]
6. Effects of dupilumab treatment on patch test reactions: A retrospective evaluation.
de Wijs LEM; van der Waa JD; Nijsten T; Silverberg JI; Kunkeler ACM; Hijnen DJ
Clin Exp Allergy; 2021 Jul; 51(7):959-967. PubMed ID: 33960047
[No Abstract] [Full Text] [Related]
7. Clinical characteristics and genetic variation in atopic dermatitis patients with and without allergic contact dermatitis.
Lee S; Wang HY; Kim E; Hwang HJ; Choi E; Lee H; Choi EH
Eur J Dermatol; 2018 Oct; 28(5):637-643. PubMed ID: 30530433
[TBL] [Abstract][Full Text] [Related]
8. Both children and adult patients with difficult-to-treat atopic dermatitis have high prevalences of concomitant allergic contact dermatitis and are frequently polysensitized.
Boonstra M; Rustemeyer T; Middelkamp-Hup MA
J Eur Acad Dermatol Venereol; 2018 Sep; 32(9):1554-1561. PubMed ID: 29578626
[TBL] [Abstract][Full Text] [Related]
9. Cutaneous delayed-type hypersensitivity in patients with atopic dermatitis.
Malajian D; Belsito DV
J Am Acad Dermatol; 2013 Aug; 69(2):232-7. PubMed ID: 23583066
[TBL] [Abstract][Full Text] [Related]
10. Allergic contact dermatitis to Compositae: A possible cause of dupilumab-associated facial and neck dermatitis in atopic dermatitis patients?
Napolitano M; Fabbrocini G; Patruno C
Contact Dermatitis; 2021 Oct; 85(4):473-474. PubMed ID: 33988858
[No Abstract] [Full Text] [Related]
11. Blocking type 2 inflammation by dupilumab does not control classic (type 1-driven) allergic contact dermatitis in chronic hand eczema.
Crepy MN; Nosbaum A; Bensefa-Colas L
Contact Dermatitis; 2019 Aug; 81(2):145-147. PubMed ID: 30851059
[No Abstract] [Full Text] [Related]
12. Impact of dupilumab on patch test results and allergic contact dermatitis: A prospective multicenter study.
Bocquel S; Soria A; Raison-Peyron N; Badaoui A; Marcant P; Bara C; Giordano-Labadie F; Amsler E; Milpied B; Delaunay J; Darrigade AS; Pralong P; Boulard C; Ferrier Le Bouedec MC; Tauber M; Pasteur J; Valois A; Le Thuaut A; Crépy MN; Bernier C
J Am Acad Dermatol; 2024 Mar; 90(3):512-520. PubMed ID: 37871801
[TBL] [Abstract][Full Text] [Related]
13. A Pragmatic Approach to Patch Testing Atopic Dermatitis Patients: Clinical Recommendations Based on Expert Consensus Opinion.
Chen JK; Jacob SE; Nedorost ST; Hanifin JM; Simpson EL; Boguniewicz M; Watsky KL; Lugo-Somolinos A; Hamann CR; Eberting CL; Silverberg JI; Thyssen JP
Dermatitis; 2016; 27(4):186-92. PubMed ID: 27427820
[TBL] [Abstract][Full Text] [Related]
14. Investigating the role of allergic contact dermatitis in residual ocular surface disease on dupilumab (ROSDD)
Raffi J; Suresh R; Fishman H; Botto N; Murase JE
Int J Womens Dermatol; 2019 Dec; 5(5):308-313. PubMed ID: 31909149
[TBL] [Abstract][Full Text] [Related]
15. Allergic contact dermatitis in atopic individuals: Results of a 30-year retrospective study.
Teo Y; McFadden JP; White IR; Lynch M; Banerjee P
Contact Dermatitis; 2019 Dec; 81(6):409-416. PubMed ID: 31347185
[TBL] [Abstract][Full Text] [Related]
16. Contact hypersensitivity to Indian standard patch test series correlates with disease severity among children with atopic dermatitis.
Handa S; Bhattacharjee R; Thakur V; De D; Mahajan R
Indian J Dermatol Venereol Leprol; 2023 [SEASON]; 90(1):46-51. PubMed ID: 37609746
[TBL] [Abstract][Full Text] [Related]
17. Occupational Chronic Contact Dermatitis Successfully Treated with Dupilumab: A Case Series.
Slodownik D; Levi A; Lapidoth M; Moshe S
Dermatology; 2022; 238(6):1073-1075. PubMed ID: 35462358
[TBL] [Abstract][Full Text] [Related]
18. Allergic contact dermatitis in patients with atopic dermatitis: A clinical study.
Sharma AD
Indian J Dermatol Venereol Leprol; 2005; 71(2):96-8. PubMed ID: 16394381
[TBL] [Abstract][Full Text] [Related]
19. The Role and Diagnosis of Allergic Contact Dermatitis in Patients with Atopic Dermatitis.
Owen JL; Vakharia PP; Silverberg JI
Am J Clin Dermatol; 2018 Jun; 19(3):293-302. PubMed ID: 29305764
[TBL] [Abstract][Full Text] [Related]
20. Rosacea associated with dupilumab therapy.
Heibel HD; Hendricks AJ; Foshee JP; Shi VY
J Dermatolog Treat; 2021 Feb; 32(1):114-116. PubMed ID: 31132923
[No Abstract] [Full Text] [Related]
[Next] [New Search]
